Mark A Kronenfeld's Net Worth
Mark A Kronenfeld's net worth is estimated to be at least $750,314.00 as of 12/23/2024. CoreStreet's estimation of Mark A Kronenfeld's net worth is based on their sale of stock and current holding of stock.
Mark A Kronenfeld is Director at Pacira Pharmaceuticals Inc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,000 units of PCRX stock on 06/08/2023. Their biggest sale was on 06/08/2023 when they sold 15,000 units of Pacira Pharmaceuticals Inc stock for $555,600.00. They typically trade 1 times per year.
Total value of insider buys:
- $152,459.00
Total value of insider sells:
- $597,855.00
Most recent insider trade:
- June 8, 2023
Mark A Kronenfeld's Insider Trading History
| Pacira Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 8, 2023 | Director | 15,000 | $37.04 | Sell | $555,600.00 |
March 6, 2019 | Director | 1,700 | $38.97 | Buy | $66,249.00 |
Aug. 28, 2018 | Director | 1,000 | $44.61 | Buy | $44,610.00 |
Nov. 10, 2017 | Director | 1,000 | $41.60 | Buy | $41,600.00 |
June 6, 2016 | Director | 900 | $46.95 | Sell | $42,255.00 |